Carret Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.8M Sell
49,839
-44
-0.1% -$9.76K 1.06% 21
2025
Q4
$11.4M Sell
49,883
-543
-1% -$124K 1.08% 20
2025
Q3
$11.7M Buy
50,426
+402
+0.8% +$81.9K 1.14% 17
2025
Q2
$9.29M Sell
50,024
-718
-1% -$133K 0.99% 22
2025
Q1
$10.6M Buy
50,742
+225
+0.4% +$43.7K 1.2% 16
2024
Q4
$8.98M Sell
50,517
-242
-0.5% -$44.5K 0.98% 22
2024
Q3
$10M Sell
50,759
-1,011
-2% -$189K 1.09% 17
2024
Q2
$8.88M Sell
51,770
-185
-0.4% -$30.6K 1.04% 21
2024
Q1
$9.46M Sell
51,955
-391
-0.7% -$67.4K 1.11% 18
2023
Q4
$8.11M Sell
52,346
-130
-0.2% -$19K 1.03% 18
2023
Q3
$7.82M Sell
52,476
-720
-1% -$106K 1.09% 16
2023
Q2
$7.17M Sell
53,196
-7,822
-13% -$1.15M 0.95% 19
2023
Q1
$9.72M Sell
61,018
-4,255
-7% -$651K 1.35% 12
2022
Q4
$10.5M Sell
65,273
-399
-0.6% -$61.2K 1.46% 12
2022
Q3
$8.81M Sell
65,672
-975
-1% -$140K 1.32% 13
2022
Q2
$10.2M Sell
66,647
-1,389
-2% -$212K 1.42% 12
2022
Q1
$11M Sell
68,036
-78
-0.1% -$11.3K 1.26% 15
2021
Q4
$9.22M Buy
68,114
+140
+0.2% +$16.5K 1.02% 19
2021
Q3
$7.33M Sell
67,974
-299
-0.4% -$34.2K 0.87% 23
2021
Q2
$7.69M Sell
68,273
-230
-0.3% -$25.9K 0.9% 22
2021
Q1
$7.41M Buy
68,503
+100
+0.1% +$10.7K 0.92% 22
2020
Q4
$7.33M Sell
68,403
-225
-0.3% -$21.6K 0.99% 22
2020
Q3
$6.01M Sell
68,628
-2,622
-4% -$247K 0.91% 29
2020
Q2
$7M Buy
71,250
+2,956
+4% +$260K 1.13% 19
2020
Q1
$5.2M Sell
68,294
-1,142
-2% -$97.3K 1% 25
2019
Q4
$6.15M Buy
69,436
+1,481
+2% +$123K 0.9% 28
2019
Q3
$5.15M Sell
67,955
-105
-0.2% -$7.2K 0.82% 35
2019
Q2
$4.95M Buy
68,060
+250
+0.4% +$19.6K 0.79% 38
2019
Q1
$5.46M Sell
67,810
-650
-0.9% -$53.2K 0.89% 29
2018
Q4
$6.31M Buy
68,460
+275
+0.4% +$24.2K 1.14% 18
2018
Q3
$6.45M Sell
68,185
-866
-1% -$82.1K 0.99% 23
2018
Q2
$6.4M Sell
69,051
-680
-1% -$66.4K 1.05% 19
2018
Q1
$6.6M Sell
69,731
-3,283
-4% -$361K 1.09% 20
2017
Q4
$7.06M Sell
73,014
-325
-0.4% -$30.6K 1.1% 20
2017
Q3
$6.52M Buy
73,339
+465
+0.6% +$35.4K 1.05% 21
2017
Q2
$5.28M Buy
72,874
+8,384
+13% +$564K 0.89% 32
2017
Q1
$4.2M Buy
64,490
+150
+0.2% +$9.43K 0.75% 39
2016
Q4
$4.03M Sell
64,340
-6,382
-9% -$390K 0.76% 41
2016
Q3
$4.46M Sell
70,722
-1,750
-2% -$113K 0.83% 37
2016
Q2
$4.49M Sell
72,472
-1,006
-1% -$61.3K 0.87% 35
2016
Q1
$4.2M Buy
73,478
+179
+0.2% +$9.98K 0.89% 37
2015
Q4
$4.34M Sell
73,299
-3,633
-5% -$209K 0.93% 34
2015
Q3
$4.19M Sell
76,932
-455
-0.6% -$29.6K 0.91% 36
2015
Q2
$5.2M Sell
77,387
-1,889
-2% -$123K 1.03% 26
2015
Q1
$4.64M Buy
79,276
+1,980
+3% +$120K 0.9% 33
2014
Q4
$5.06M Sell
77,296
-196
-0.3% -$12.4K 0.96% 33
2014
Q3
$4.48M Sell
77,492
-2,350
-3% -$130K 0.87% 34
2014
Q2
$4.51M Sell
79,842
-897
-1% -$47.1K 0.86% 34
2014
Q1
$4.15M Buy
80,739
+910
+1% +$46K 0.83% 39
2013
Q4
$4.22M Sell
79,829
-3,486
-4% -$171K 0.86% 39
2013
Q3
$3.73M Buy
83,315
+315
+0.4% +$14K 0.83% 41
2013
Q2
$3.43M Buy
+83,000
New +$3.63M 0.71% 41

Other funds holding ABBV

Carret Asset Management's ABBV Position: Q1 2026 in Review

Carret Asset Management reduced its AbbVie (ABBV) stake by 0.09% in Q1 2026, selling an estimated $9.76K and leaving 49,839 shares worth $10.8M. The position accounts for 1.06% of the portfolio, ranked #21.

Carret Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.7M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Carret Asset Management held 49,839 shares of AbbVie worth $10.8M as of Q1 2026.
  • Carret Asset Management sold 44 AbbVie shares in Q1 2026, an estimated $9.76K.
  • AbbVie made up 1.06% of Carret Asset Management's portfolio in Q1 2026, its #21 holding.
  • Carret Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Carret Asset Management's AbbVie position peaked at $11.7M in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Carret Asset Management's 13F filing for Q1 2026, filed 15 May 2026.